- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate Neoplasms in New Zealand
Total 16852 results
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedProstate CancerUnited States
-
Duke UniversityAstellas Pharma Inc; Medivation, Inc.CompletedProstate CancerUnited States
-
Duke UniversitySanofi; PfizerTerminated
-
Eli Lilly and CompanySarah Cannon Development InnovationsCompletedProstate Cancer MetastaticUnited States
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
Bristol-Myers SquibbCompletedProstate CancerUnited States
-
AmgenActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; Stand Up To CancerActive, not recruitingMetastatic Prostate CancerUnited States
-
Royal North Shore HospitalWithdrawn
-
BioProtectCompletedProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedStage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | PSA Level Five to Ten | PSA Level Less Than Five | PSA Level Ten to FiftyUnited States
-
Biotech Equity Partners Pty LtdUnknownProstate CancerAustralia
-
AstraZenecaCompletedMetastatic Castration-resistant Prostates CancerIndia, Peru, Saudi Arabia, Egypt, Colombia, Korea, Republic of, Turkey, United Arab Emirates
-
Rutgers, The State University of New JerseyBristol-Myers Squibb; National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
BayerActive, not recruitingNon-metastatic Castration-resistant Prostate CancerUnited States
-
BayerCompletedNon-metastatic Castration-resistant Prostate CancerUnited States
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Hormone-refractory Prostate CancerUnited States
-
Vanderbilt UniversityPatient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Emory... and other collaboratorsCompletedProstate CancerUnited States
-
University of SydneyTrans Tasman Radiation Oncology GroupUnknownProstate CancerAustralia
-
Royal North Shore HospitalCompletedCancer of the ProstateAustralia
-
Boston Scientific CorporationSuspendedCancer | ProstateUnited States
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedProstate Cancer | Precancerous/Nonmalignant ConditionUnited States
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
Effector TherapeuticsCompletedCastrate-resistant Prostate Cancer (CRPC)United States
-
Steba Biotech S.A.Active, not recruitingLocalized Prostate CancerUnited States
-
GenomeDx Biosciences CorpColumbia UniversityCompleted
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
Cougar Biotechnology, Inc.CompletedProstate NeoplasmsUnited States, United Kingdom
-
Rutgers, The State University of New JerseyMemorial Sloan Kettering Cancer Center; Fox Chase Cancer Center; Rutgers Cancer...CompletedProstate Cancer | Sexuality | Sexual Dysfunction and InfertilityUnited States
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
PROCEPT BioRoboticsRecruitingLocalized Prostate CancerUnited States
-
Exosome Diagnostics, Inc.Terminated
-
Icahn School of Medicine at Mount SinaiCompleted
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; M.D. Anderson Cancer Center; Mayo Clinic; Baylor College... and other collaboratorsCompleted
-
MEI Pharma, Inc.CompletedProstate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Completed
-
University of Wisconsin, MadisonMadison Vaccines IncorporatedCompletedProstate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedProstate CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark